Chancy Fessler
About Chancy Fessler
Chancy Fessler is a Senior Supervisor of Facilities Operations at Nektar Therapeutics, where he has worked since 2020 in the San Francisco Bay Area. He has a strong background in research and operations, having held various roles at KineMed, Inc and Nektar Therapeutics over the past two decades.
Work at Nektar Therapeutics
Chancy Fessler has been employed at Nektar Therapeutics since 2020, currently holding the position of Sr. Supervisor in Facilities Operations. In this role, Fessler has contributed significantly to the management of facility operations, including the determination and enforcement of COVID-related protocols. Fessler has also played a vital role in overseeing the timelines for new laboratory equipment and managing personal protective equipment (PPE) supplies for the San Francisco site. Prior to the current role, Fessler served in various capacities at Nektar, including Associate Scientist and Sr. Research Associate in Discovery Chemistry.
Previous Experience at KineMed, Inc
Before joining Nektar Therapeutics, Chancy Fessler worked at KineMed, Inc from 2005 to 2016, where they held multiple positions in the Analytical Core. Fessler started as a Staff Research Associate I and progressed to Staff Research Associate III. During this time, Fessler gained extensive experience in research operations, contributing to various analytical projects. This experience laid the foundation for Fessler's subsequent roles in the pharmaceutical industry.
Education and Expertise
Chancy Fessler earned a Master of Science in Forensic Sciences from the University of California, Davis, completing the program from 2002 to 2005. Prior to this, Fessler obtained a Bachelor of Science in Biochemistry from the same institution, studying from 1996 to 2000. This educational background provides a strong foundation in scientific principles and analytical techniques, which are essential in the field of facilities operations and research.
Key Contributions and Initiatives
In the role of Sr. Supervisor at Nektar Therapeutics, Chancy Fessler has made significant contributions to the organization. Fessler successfully eliminated a backlog of new equipment records by coordinating with vendors and internal departments. Additionally, Fessler was instrumental in the new laboratory build-out team, providing insights from a laboratory user perspective. These contributions have enhanced operational efficiency and supported the organization's research capabilities.